DOH has formally demanded refund for Dengvaxia | Inquirer News

DOH has formally demanded refund for Dengvaxia

By: - Reporter / @santostinaINQ
/ 09:20 PM January 29, 2018

Francisco Duque III

Health Secretary Francisco Duque III (File photo by LYN RILLON / Philippine Daily Inquirer)

The Department of Health (DOH) has formally demanded French pharmaceutical giant Sanofi Pasteur to fully refund the Philippine government the P3 billion it paid for the controversial Dengvaxia dengue vaccine.

In an interview with reporters late Monday afternoon, Health Secretary Francisco Duque III said he sent the demand letter to Sanofi last Jan. 26.

Article continues after this advertisement

The demand letter was for the refund of almost P2 billion used vaccines.

FEATURED STORIES

Sanofi earlier returned over P1 billion to the Philippine government for the unused Dengvaxia.

“We already sent the letter for the refund of the used vaccines because the purported protection wasn’t felt, wasn’t there,” Duque said.

Article continues after this advertisement

“In fact they withdrew the label. They did a relabeling because they said you can no longer use this for seronegative children who never had past dengue infection,” he added.

Article continues after this advertisement

Duque also gave regional directors and DOH hospitals marching orders on how they should monitor and manage cases of vaccinated children who might develop dengue.

Article continues after this advertisement

He said this would includes ensuring that hospitalization costs of the Dengvaxia vaccinated children would covered by the Philippine Health Insurance Corp. (PhilHealth).

Duque is also seeking legislative reforms, including strengthening Research Institute for Tropical Medicine (RITM) as mandatory research arm of DOH and strengthening the independence of the Food and Drug Administration.

Article continues after this advertisement

“In the case of RITM, we want to ensure that checks and balances are fully in placed and it will not be influenced or under undue interference by the industry,” Duque said.  “We also want to strengthen the independence of FDA in exercising its mandate to protect the public in regulating health products.” /atm

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Dengvaxia, DoH

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.